Clearside Biomedical, Inc.CLSDNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank58
3Y CAGR+0.1%
5Y CAGR+3.5%
Year-over-Year Change
Research and development spending
3Y CAGR
+0.1%/yr
vs -21.6%/yr prior
5Y CAGR
+3.5%/yr
Recent deceleration
Acceleration
+21.7pp
Accelerating
Percentile
P58
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $18.59M | -10.8% |
| 2023 | $20.85M | +6.2% |
| 2022 | $19.63M | +5.9% |
| 2021 | $18.54M | +23.0% |
| 2020 | $15.07M | -3.7% |
| 2019 | $15.66M | -77.1% |
| 2018 | $68.29M | +39.2% |
| 2017 | $49.05M | +152.1% |
| 2016 | $19.45M | +80.8% |
| 2015 | $10.76M | - |